Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

61.13M

Market cap61.13M

Price-Earnings ratio

-2.13

Price-Earnings ratio-2.13

Dividend yield

—

Dividend yield—

Average volume

149.79K

Average volume149.79K

High today

$4.29

High today$4.29

Low today

$4.10

Low today$4.10

Open price

$4.20

Open price$4.20

Volume

62.05K

Volume62.05K

52 Week high

$14.20

52 Week high$14.20

52 Week low

$2.64

52 Week low$2.64

VERU News

Simply Wall St 7d

October 2025's Noteworthy Penny Stocks

As the U.S. stock market rebounds with major indexes like the S&P 500 hitting new all-time highs, investors are keenly observing the Federal Reserve's recent in...

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.